Crossref journal-article
Public Library of Science (PLoS)
PLoS ONE (340)
Authors 7
  1. Ali Alejo (first)
  2. Margarida Saraiva (additional)
  3. Maria Begoña Ruiz-Argüello (additional)
  4. Abel Viejo-Borbolla (additional)
  5. Mar Fernández de Marco (additional)
  6. Francisco Javier Salguero (additional)
  7. Antonio Alcami (additional)
References 59 Referenced 24
  1. {'key': 'ref1', 'first-page': '2905', 'article-title': 'Poxviridae: The Viruses and their replication.', 'author': 'B Moss', 'year': '2007'} / Poxviridae: The Viruses and their replication. by B Moss (2007)
  2. 10.1016/S1473-3099(03)00856-9 / Lancet Infect Dis / Human monkeypox: an emerging zoonosis. by DB Di Giulio (2004)
  3. 10.1099/vir.0.81090-0 / J Gen Virol / Ectromelia virus: the causative agent of mousepox. by DJ Esteban (2005)
  4. {'key': 'ref4', 'first-page': '535', 'article-title': 'Mousepox.', 'author': 'RML Fenner FaB', 'year': '1997'} / Mousepox. by RML Fenner FaB (1997)
  5. 10.1128/JVI.69.9.5875-5877.1995 / J Virol / Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. by ML Delano (1995)
  6. 10.1371/journal.ppat.0040030 / PLoS Pathog / A role for NKG2D in NK cell-mediated resistance to poxvirus disease. by M Fang (2008)
  7. 10.1073/pnas.0402949101 / Proc Natl Acad Sci U S A / Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox. by G Chaudhri (2004)
  8. 10.1128/JVI.00115-06 / J Virol / Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function. by V Panchanathan (2006)
  9. 10.1128/JVI.00116-06 / J Virol / Obligatory requirement for antibody in recovery from a primary poxvirus infection. by G Chaudhri (2006)
  10. 10.1016/0092-8674(92)90274-G / Cell / A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. by A Alcami (1992)
  11. 10.1016/0092-8674(92)90273-F / Cell / Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. by MK Spriggs (1992)
  12. 10.1016/0092-8674(95)90076-4 / Cell / Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. by JA Symons (1995)
  13. 10.1074/jbc.270.27.15974 / J Biol Chem / Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. by OR Colamonici (1995)
  14. 10.1016/S1074-7613(00)80552-X / Immunity / A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. by MR Comeau (1998)
  15. 10.1128/JVI.71.6.4857-4861.1997 / J Virol / A homolog of interleukin-10 is encoded by the poxvirus orf virus. by SB Fleming (1997)
  16. 10.1099/vir.0.79980-0 / J Gen Virol / A new member of the interleukin 10-related cytokine family encoded by a poxvirus. by NW Bartlett (2004)
  17. 10.1038/nri980 / Nat Rev Immunol / Viral mimicry of cytokines, chemokines and their receptors. by A Alcami (2003)
  18. 10.1146/annurev.immunol.21.120601.141049 / Annu Rev Immunol / Poxviruses and immune evasion. by BT Seet (2003)
  19. 10.1016/j.cell.2006.01.034 / Cell / Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. by BB Finlay (2006)
  20. 10.1006/mgme.1999.2878 / Mol Genet Metab / Tumor necrosis factor receptors encoded by poxviruses. by KM Cunnion (1999)
  21. {'key': 'ref21', 'first-page': '269', 'article-title': 'Secreted tumour necrosis factor inhibitors encoded by poxviruses.', 'author': 'MB Ruiz-Argüello', 'year': '2005'} / Secreted tumour necrosis factor inhibitors encoded by poxviruses. by MB Ruiz-Argüello (2005)
  22. 10.1371/journal.ppat.0020004 / PLoS Pathog / Modulation of tumor necrosis factor by microbial pathogens. by MM Rahman (2006)
  23. 10.1073/pnas.0737244100 / Proc Natl Acad Sci U S A / A secreted high-affinity inhibitor of human TNF from Tanapox virus. by CR Brunetti (2003)
  24. 10.1074/jbc.M604645200 / J Biol Chem / Variation in ligand binding specificities of a novel class of poxvirus-encoded tumor necrosis factor-binding protein. by MM Rahman (2006)
  25. 10.1099/0022-1317-80-4-949 / J Gen Virol / Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. by A Alcami (1999)
  26. 10.1073/pnas.0510462103 / Proc Natl Acad Sci U S A / A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. by A Alejo (2006)
  27. 10.1006/viro.1994.1539 / Virology / Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. by FQ Hu (1994)
  28. 10.1073/pnas.95.7.3786 / Proc Natl Acad Sci U S A / A third distinct tumor necrosis factor receptor of orthopoxviruses. by VN Loparev (1998)
  29. 10.1128/JVI.75.1.226-233.2001 / J Virol / CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. by M Saraiva (2001)
  30. 10.1073/pnas.122238599 / Proc Natl Acad Sci U S A / Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue. by JF Panus (2002)
  31. 10.1084/jem.20020319 / J Exp Med / Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. by M Saraiva (2002)
  32. 10.1128/JVI.75.22.10856-10869.2001 / J Virol / Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection. by GL Demmin (2001)
  33. 10.1128/JVI.64.6.3108-3111.1990 / J Virol / Transient dominant selection of recombinant vaccinia viruses. by FG Falkner (1990)
  34. 10.1016/S0378-1119(00)00398-X / Gene / Puromycin resistance (pac) gene as a selectable marker in vaccinia virus. by JM Sanchez-Puig (2000)
  35. 10.1111/j.1462-5822.2004.00423.x / Cell Microbiol / Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes. by JB Johnston (2004)
  36. 10.1016/0022-2836(89)90108-3 / J Mol Biol / Structure of vaccinia virus late promoters. by AJ Davison (1989)
  37. 10.1073/pnas.192420599 / Proc Natl Acad Sci U S A / Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. by A Domi (2002)
  38. 10.1371/journal.pone.0001638 / PLoS ONE / Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA). by MG Cottingham (2008)
  39. 10.1006/viro.1993.1525 / Virology / In vitro and in vivo study of the ectromelia virus homolog of the vaccinia virus K1L host range gene. by W Chen (1993)
  40. 10.1016/0168-1702(94)90118-X / Virus Res / Fine mechanisms of ectromelia virus thymidine kinase-negative mutants avirulence. by GV Kochneva (1994)
  41. 10.1074/jbc.M410583200 / J Biol Chem / The poxvirus p28 virulence factor is an E3 ubiquitin ligase. by J Huang (2004)
  42. 10.1006/viro.1994.1014 / Virology / A Poxvirus Protein with a RING Zinc Finger Motif Is of Crucial Importance for Virulence. by TG Senkevich (1994)
  43. 10.1128/JVI.69.7.4103-4111.1995 / J Virol / Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. by TG Senkevich (1995)
  44. 10.4049/jimmunol.164.6.3246 / J Immunol / A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. by TL Born (2000)
  45. 10.1128/JVI.01927-06 / J Virol / Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection. by IG Sakala (2007)
  46. {'key': 'ref46', 'article-title': 'The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination.', 'author': 'R-H Xu', 'year': '2008', 'journal-title': 'J Exp Med'} / J Exp Med / The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination. by R-H Xu (2008)
  47. 10.1002/prot.21541 / Proteins / The conformation of the extracellular binding domain of Death Receptor 5 in the presence and absence of the activating ligand TRAIL: a molecular dynamics study. by TA Wassenaar (2008)
  48. 10.1016/j.cyto.2007.03.005 / Cytokine / Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling. by FK Chan (2007)
  49. 10.1016/j.bbapap.2006.09.006 / Biochim Biophys Acta / Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different. by IP Gileva (2006)
  50. 10.1073/pnas.0705753105 / Proc Natl Acad Sci U S A / Structure and mechanism of IFN-gamma antagonism by an orthopoxvirus IFN-gamma-binding protein. by AA Nuara (2008)
  51. 10.4049/jimmunol.181.9.6316 / J Immunol / A Novel Role of CD30L/CD30 Signaling by T-T Cell Interaction in Th1 Response against Mycobacterial Infection. by C Tang (2008)
  52. 10.4049/jimmunol.165.2.786 / J Immunol / Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. by A Cerutti (2000)
  53. 10.1111/j.1365-2567.2006.02354.x / Immunology / Deciphering CD30 ligand biology and its role in humoral immunity. by MK Kennedy (2006)
  54. 10.4049/jimmunol.175.7.4627 / J Immunol / A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells. by H Nishimura (2005)
  55. 10.1128/JVI.00945-06 / J Virol / Genome of horsepox virus. by ER Tulman (2006)
  56. 10.1016/0966-842X(96)10051-2 / Trends Microbiol / Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus. by A Alcami (1996)
  57. 10.1128/JVI.79.2.966-977.2005 / J Virol / Genome of deerpox virus. by CL Afonso (2005)
  58. {'key': 'ref58', 'first-page': '191', 'article-title': 'The construction and characterization of vaccinia virus recombinants expressing foreign genes', 'year': '1985'} / The construction and characterization of vaccinia virus recombinants expressing foreign genes (1985)
  59. 10.1099/0022-1317-78-8-2041 / J Gen Virol / Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. by A Vanderplasschen (1997)
Dates
Type When
Created 16 years, 4 months ago (April 10, 2009, 7:26 p.m.)
Deposited 5 years, 3 months ago (May 17, 2020, 8:11 a.m.)
Indexed 2 weeks ago (Aug. 20, 2025, 8:24 a.m.)
Issued 16 years, 4 months ago (April 13, 2009)
Published 16 years, 4 months ago (April 13, 2009)
Published Online 16 years, 4 months ago (April 13, 2009)
Funders 0

None

@article{Alejo_2009, title={A Method for the Generation of Ectromelia Virus (ECTV) Recombinants: In Vivo Analysis of ECTV vCD30 Deletion Mutants}, volume={4}, ISSN={1932-6203}, url={http://dx.doi.org/10.1371/journal.pone.0005175}, DOI={10.1371/journal.pone.0005175}, number={4}, journal={PLoS ONE}, publisher={Public Library of Science (PLoS)}, author={Alejo, Ali and Saraiva, Margarida and Ruiz-Argüello, Maria Begoña and Viejo-Borbolla, Abel and de Marco, Mar Fernández and Salguero, Francisco Javier and Alcami, Antonio}, editor={Masucci, Maria G.}, year={2009}, month=apr, pages={e5175} }